Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 426 publications

Bioequivalence and Pharmacokinetics of Low-Dose Anagrelide 0.5 mg Capsules in Healthy Volunteers.

Bioequivalence and Pharmacokinetics of Low-Dose Anagrelide 0.5 mg Capsules in Healthy Volunteers.

Journal: Biomedicines
Published: July 19, 2025

Leukocytoclastic Vasculitis in JAK2-Positive Essential Thrombocythemia: A Case of Cytokine-Driven Urticarial Rash Responsive to Ruxolitinib.

Leukocytoclastic Vasculitis in JAK2-Positive Essential Thrombocythemia: A Case of Cytokine-Driven Urticarial Rash Responsive to Ruxolitinib.

Journal: European journal of case reports in internal medicine
Published: June 10, 2025

An Unusual Case of Essential Thrombocythemia and Acute Kidney Injury: Case Report and Literature Review.

An Unusual Case of Essential Thrombocythemia and Acute Kidney Injury: Case Report and Literature Review.

Journal: Diseases (Basel, Switzerland)
Published: April 05, 2025

Advances in the diagnosis and treatment of thrombocytosis in children

Advances in the diagnosis and treatment of thrombocytosis in children

Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Published: February 18, 2025

Identification of anticancer drugs associated to cancer therapy-related cardiac dysfunction: a VigiBase® disproportionality analysis.

Identification of anticancer drugs associated to cancer therapy-related cardiac dysfunction: a VigiBase® disproportionality analysis.

Journal: European heart journal. Cardiovascular pharmacotherapy
Published: February 17, 2025

Identification of Anticancer Drugs Associated to Cancer Therapy-Related Cardiac Dysfunction: A VigiBase® Disproportionality Analysis.

Identification of Anticancer Drugs Associated to Cancer Therapy-Related Cardiac Dysfunction: A VigiBase® Disproportionality Analysis.

Journal: European heart journal. Cardiovascular pharmacotherapy
Published: February 17, 2025

Real-world characteristics and treatment patterns in essential thrombocythemia: a population-based cross-sectional study in Taiwan between 2020 and 2021.

Real-world characteristics and treatment patterns in essential thrombocythemia: a population-based cross-sectional study in Taiwan between 2020 and 2021.

Journal: Therapeutic advances in hematology
Published: February 13, 2025

Pharmacokinetic profile and in vivo anticancer efficacy of anagrelide administered subcutaneously in rodents.

Pharmacokinetic profile and in vivo anticancer efficacy of anagrelide administered subcutaneously in rodents.

Journal: Drug delivery
Published: February 11, 2025

Thrombosis at Unusual Sites: Focus on Myeloproliferative Neoplasms and Paroxysmal Nocturnal Hemoglobinuria.

Thrombosis at Unusual Sites: Focus on Myeloproliferative Neoplasms and Paroxysmal Nocturnal Hemoglobinuria.

Journal: Hamostaseologie
Published: February 03, 2025

Anagrelide in the management of essential thrombocythemia: a systemic review and meta-analysis.

Anagrelide in the management of essential thrombocythemia: a systemic review and meta-analysis.

Journal: International journal of hematology
Published: January 07, 2025

A Case of Essential Thrombocythemia Treated for Epileptic Peri-Ictal Psychiatric Symptoms Resulting in Appropriate Palliative Care.

A Case of Essential Thrombocythemia Treated for Epileptic Peri-Ictal Psychiatric Symptoms Resulting in Appropriate Palliative Care.

Journal: Cureus
Published: December 31, 2024

Initial Low-Dose Hydroxyurea and Anagrelide Combination in Essential Thrombocythemia: Comparable Response with Lower Toxicity.

Initial Low-Dose Hydroxyurea and Anagrelide Combination in Essential Thrombocythemia: Comparable Response with Lower Toxicity.

Journal: Journal of clinical medicine
Published: March 24, 2024
Showing 1-12 of 426

Last Updated: 10/31/2025